The Sunrise OSA Trial

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 21, 2021

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

Sunrise

"Sunrise (Sunrise SA, Belgium) is a novel integrated digital medicine solution for the diagnosis of OSA allowing the detection of respiratory disorders from the analysis of mandibular movements optimised by an artificial intelligence algorithm machine learning. It is composed of a unique innovative sensor, placed on the chin during the night, connected via Bluetooth to a mobile application which guides the patients for the implementation and allows the transfer of the data collected by the sensor to a certified health host guaranteeing the security and confidentiality of medical data. The analysed data is integrated and automatically transferred into a detailed report made available to doctors via a secure website the day after the test."

DEVICE

Polygraphy

Polygraphy (Apnoealink-Air, ResMed, Australia) is a commercially available, limited-channel sleep study device which can be used in the home. Many sleep services in the UK already use the ApneaLink Air for routine screening. It is a portable device which consists of a nasal cannula to measure nasal flow and snoring, oximeter to measure pulse and blood oxygen levels, and a chest band to measure respiratory effort. It contains software which allows for the scoring of apnoeas, hypopnoea and arousals.

Trial Locations (2)

IV2 3UJ

Raigmore Hospital, Inverness

SW3 6NP

Royal Brompton Hospital, London

All Listed Sponsors
collaborator

NHS Highlands

OTHER

lead

Royal Brompton & Harefield NHS Foundation Trust

OTHER

NCT05204004 - The Sunrise OSA Trial | Biotech Hunter | Biotech Hunter